Form D · Biotechnology

Peloton Therapeutics, Inc.

Dallas, TX · CIK 0001525145

Offering snapshot reported Oct 4, 2012 · SEC filing

Reported sold
$11.7M
Offering amount: $20M
Investors reported
4
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 30, 2011
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.85M$11.7MJul 14, 2011: $2,000,000.00Jul 14, 2011Oct 4, 2012: $11,700,000.00Oct 4, 2012

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,000,000 → $11,700,000
  • Reported investors1 → 4

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 4, 2012Amendment$11,700,000$9,700,000vs Jul 14, 20114SEC filing
Jul 14, 2011Initial$2,000,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-162891

Source: Form D, filed Oct 4, 2012. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Brown Director
John Creecy Director
David Goeddel Director
John Josey Executive
Tim Kutzkey Director, Executive
Brett Ringle Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2330 Inwood Rd. Suite 226
Dallas, TX, 75235